Close
ACHEMA MIDDLE EAST 2026

Australia Encourages Further COVID-19 Vaccination Research

In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants emerge, the Australian government...

US Study Finds COVID Raises Long-Term Brain Injury Risk

According to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a variety of brain damage...

Herpes By Being Genetically Altered Fights Severe Cancers

A quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form of the herpes simplex...

canSERV Offers Cancer Research Solutions Throughout Europe

Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business...

WHO Advocates For More Research For Long COVID Patients

The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously. At least 17 million...

First Patient Has Been Enrolled In The Sevuparin Experiment

The treatment for paediatric patients with severe malaria is being evaluated through research. The first patient has been enrolled in the SEVUSMART study, according to...

NHS To Offer Variant-Busting Booster Before The Winters

The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...